Concourse Financial Group Securities’s Vanda Pharmaceuticals VNDA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Hold |
0
| – | – | – | 8171 |
|
|
2024
Q4 | – | Hold |
0
| – | – | – | 8397 |
|
|
2024
Q3 | – | Hold |
0
| – | – | – | 8399 |
|
|
2024
Q2 | – | Hold |
0
| – | – | – | 8411 |
|
|
2024
Q1 | – | Hold |
0
| – | – | – | 8414 |
|
|
2023
Q4 | – | Hold |
0
| – | – | – | 8347 |
|
|
2023
Q3 | – | Hold |
0
| – | – | – | 8143 |
|
|
2023
Q2 | – | Hold |
0
| – | – | – | 7937 |
|
|
2023
Q1 | – | Hold |
0
| – | – | – | 7646 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 7653 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 7476 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 7376 |
|
|
2022
Q1 | – | Hold |
0
| – | – | – | 7237 |
|
|
2021
Q4 | – | Hold |
0
| – | – | – | 7120 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 6890 |
|
|
2021
Q2 | – | Hold |
0
| – | – | – | 6643 |
|
|
2021
Q1 | – | Hold |
0
| – | – | – | 6415 |
|
|
2020
Q4 | – | Hold |
0
| – | – | – | 6217 |
|
|
2020
Q3 | – | Hold |
0
| – | – | – | 6005 |
|
|
2020
Q2 | – | Hold |
0
| – | – | – | 5848 |
|
|
2020
Q1 | – | Hold |
0
| – | – | – | 5782 |
|
|
2019
Q4 | – | Hold |
0
| – | – | – | 5693 |
|
|
2019
Q3 | – | Hold |
0
| – | – | – | 5530 |
|
|
2019
Q2 | – | Sell |
-61
| Closed | -$1K | – | 5575 |
|
|
2019
Q1 | $1K | Buy |
+61
| New | +$1K | ﹤0.01% | 2191 |
|
|
2018
Q4 | – | Hold |
0
| – | – | – | 5387 |
|
|
2018
Q3 | – | Hold |
0
| – | – | – | 5212 |
|